Company Profile For Medtronic, Inc.

Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Through these seven segments, the Company develops, manufactures and markets its medical devices in more than 120 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose and throat conditions. The primary markets for products are the United States, Western Europe and Japan. In July 2008, it acquired Restore Medical, Inc. In November 2008, Medtronic acquired CryoCath Technologies Inc. In February 2009, it acquired Ablation Frontiers, Inc. and Ventor Technologies Ltd. In April 2009, Medtronic acquired CoreValve, Inc.

BRIEF: For the thirteen week ended 31 July 2009, Medtronic, Inc.'s revenues rose 6% to $3.93B. Net income fell 38% to $445M. Revenues reflect an increase in income from Cardiac Rhythm Disease Management, Spinal, Cardio Vascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control segments. Net income was offset by higher research & development expense and an increase in selling, general & administrative expenses.

Medtronic, Inc.
710 Medtronic Parkway
LC-480
Minneapolis   MN   55432
P: +1763.5052692
F: +1763.5146272

37665